7.20
-0.0252(-0.35%)
Currency In USD
Address
3963 Maple Avenue
Dallas, TX 75219
United States of America
Phone
972 499 3350
Website
Sector
Healthcare
Industry
Biotechnology
Employees
14
First IPO Date
March 19, 2021
| Name | Title | Pay | Year Born |
| Bronson Crouch | Chairman & Chief Executive Officer | 1.65M | 1973 |
| Sandeep Laumas | Chief Financial Officer & Chief Business Officer | 1.02M | 1969 |
| James Freedman | Chief Medical Officer | 0 | N/A |
| Qiying Lu | Chief Medical Officer & Senior Vice President of China | 0 | 1975 |
| Rupal Bhatt | Senior Vice President of Science & Translational Medicine | 0 | N/A |
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.